Published in J Virol on December 01, 1993
Expression of hepatitis delta virus RNA deletions: cis and trans requirements for self-cleavage, ligation, and RNA packaging. J Virol (1994) 1.93
RNA-Dependent replication and transcription of hepatitis delta virus RNA involve distinct cellular RNA polymerases. Mol Cell Biol (2000) 1.36
Specific HDV RNA-templated transcription by pol II in vitro. RNA (2000) 1.36
Rolling circle replication of hepatitis delta virus RNA is carried out by two different cellular RNA polymerases. J Virol (2002) 1.28
Identification and characterization of a hepatitis delta virus RNA transcriptional promoter. J Virol (1996) 1.27
Nucleotide sequence stability of the genome of hepatitis delta virus. J Virol (1995) 1.27
A pseudoknot ribozyme structure is active in vivo and required for hepatitis delta virus RNA replication. J Virol (1996) 1.25
Effects of nucleotide changes on the ability of hepatitis delta virus to transcribe, process, and accumulate unit-length, circular RNA. J Virol (1997) 1.24
Evidence that two latency-associated transcripts of herpes simplex virus type 1 are nonlinear. J Virol (1996) 1.23
Host RNA polymerase requirements for transcription of the human hepatitis delta virus genome. J Virol (2001) 1.21
Redistribution of the delta antigens in cells replicating the genome of hepatitis delta virus. J Virol (1996) 1.21
RNA replication without RNA-dependent RNA polymerase: surprises from hepatitis delta virus. J Virol (2005) 1.21
RNA recombination in vivo in the absence of viral replication. J Virol (2004) 1.16
Introduction of hepatitis delta virus into animal cell lines via cationic liposomes. J Virol (1994) 1.15
Enhancer-like activity of a brome mosaic virus RNA promoter. J Virol (2003) 1.13
Hepatitis delta antigen mediates the nuclear import of hepatitis delta virus RNA. J Virol (1998) 1.12
Origin of hepatitis delta virus mRNA. J Virol (2000) 1.10
Hepatitis delta antigens enhance the ribozyme activities of hepatitis delta virus RNA in vivo. J Virol (1996) 1.09
Initiation of hepatitis delta virus genome replication. J Virol (1998) 1.06
Hepatitis delta virus mutant: effect on RNA editing. J Virol (1995) 1.05
Intracellular cleavage and ligation of hepatitis delta virus genomic RNA: regulation of ribozyme activity by cis-acting sequences and host factors. J Virol (1995) 1.04
Localization of hepatitis delta virus RNA in the nucleus of human cells. RNA (1998) 1.02
Transgenic mice support replication of hepatitis delta virus RNA in multiple tissues, particularly in skeletal muscle. J Virol (1995) 0.99
Functional domains of delta antigens and viral RNA required for RNA packaging of hepatitis delta virus. J Virol (1995) 0.95
The conserved serine 177 in the delta antigen of hepatitis delta virus is one putative phosphorylation site and is required for efficient viral RNA replication. J Virol (2001) 0.93
Interaction of host cellular proteins with components of the hepatitis delta virus. Viruses (2010) 0.89
Apparent helper-independent infection of woodchucks by hepatitis delta virus and subsequent rescue with woodchuck hepatitis virus. J Virol (1994) 0.88
Casein kinase II and protein kinase C modulate hepatitis delta virus RNA replication but not empty viral particle assembly. J Virol (1996) 0.88
Determination of the multimerization state of the hepatitis delta virus antigens in vivo. J Virol (2003) 0.88
Transcription of subgenomic mRNA of hepatitis delta virus requires a modified hepatitis delta antigen that is distinct from antigenomic RNA synthesis. J Virol (2008) 0.87
Activation of heterologous gene expression by the large isoform of hepatitis delta antigen. J Virol (1998) 0.86
Formation of an RNA polymerase II preinitiation complex on an RNA promoter derived from the hepatitis delta virus RNA genome. Nucleic Acids Res (2008) 0.86
Epitopes exposed on hepatitis delta virus ribonucleoproteins. J Virol (1996) 0.85
Hepatitis delta virus RNA replication. Viruses (2009) 0.84
Nucleolar targeting of hepatitis delta antigen abolishes its ability to initiate viral antigenomic RNA replication. J Virol (2007) 0.83
Hepatitis delta virus: a peculiar virus. Adv Virol (2013) 0.82
Phosphorylation of serine 177 of the small hepatitis delta antigen regulates viral antigenomic RNA replication by interacting with the processive RNA polymerase II. J Virol (2009) 0.81
Identification of a binding site for ASF/SF2 on an RNA fragment derived from the hepatitis delta virus genome. PLoS One (2013) 0.76
SV40-transformed simian cells support the replication of early SV40 mutants. Cell (1981) 34.67
Growth of human hepatoma cells lines with differentiated functions in chemically defined medium. Cancer Res (1982) 11.72
Structure, sequence and expression of the hepatitis delta (delta) viral genome. Nature (1986) 7.38
Controlled synthesis of HBsAg in a differentiated human liver carcinoma-derived cell line. Nature (1979) 6.76
Initiation of replication of the human hepatitis delta virus genome from cloned DNA: role of delta antigen. J Virol (1989) 5.48
Structure and replication of the genome of the hepatitis delta virus. Proc Natl Acad Sci U S A (1986) 5.23
Molecular cloning of hepatitis delta virus RNA from an infected woodchuck liver: sequence, structure, and applications. J Virol (1988) 4.96
Antigenomic RNA of human hepatitis delta virus can undergo self-cleavage. J Virol (1988) 4.59
Characterization of self-cleaving RNA sequences on the genome and antigenome of human hepatitis delta virus. J Virol (1988) 4.05
The hepatitis delta (delta) virus possesses a circular RNA. Nature (1986) 4.00
Inhibition of in vivo and in vitro transcription by monoclonal antibodies prepared against wheat germ RNA polymerase II that react with the heptapeptide repeat of eukaryotic RNA polymerase II. J Biol Chem (1989) 3.90
Functional steps in transcription initiation and reinitiation from the major late promoter in a HeLa nuclear extract. J Biol Chem (1987) 2.95
Advances in RNA polymerase II transcription. Curr Opin Cell Biol (1992) 2.81
Hepatitis delta virus genome replication: a polyadenylated mRNA for delta antigen. J Virol (1990) 2.03
Assembly and disassembly of the Drosophila RNA polymerase II complex during transcription. J Biol Chem (1990) 1.89
RNA intermediates in potato spindle tuber viroid replication. Proc Natl Acad Sci U S A (1982) 1.85
In vitro-synthesized hepatitis delta virus RNA initiates genome replication in cultured cells. J Virol (1990) 1.79
Self-ligating RNA sequences on the antigenome of human hepatitis delta virus. J Virol (1989) 1.78
The antigen of hepatitis delta virus: examination of in vitro RNA-binding specificity. J Virol (1991) 1.70
Hepatitis delta antigen is necessary for access of hepatitis delta virus RNA to the cell transcriptional machinery but is not part of the transcriptional complex. Virology (1991) 1.69
Circular RNAs: relics of precellular evolution? Proc Natl Acad Sci U S A (1989) 1.63
Replication of RNA by the DNA-dependent RNA polymerase of phage T7. Cell (1989) 1.63
DNA-dependent RNA polymerase II of plant origin transcribes viroid RNA into full-length copies. Nature (1981) 1.60
Ribonucleoprotein complexes of hepatitis delta virus. J Virol (1993) 1.56
Synthesis of (+) and (-) RNA molecules of potato spindle tuber viroid (PSTV) in isolated nuclei and its impairment by transcription inhibitors. Biosci Rep (1985) 1.38
Ribonuclease T1 generates circular RNA molecules from viroid-specific RNA transcripts by cleavage and intramolecular ligation. Nucleic Acids Res (1991) 1.24
Recent developments in hepatitis delta virus research. Adv Virus Res (1994) 1.23
Structure of RNAs replicated by the DNA-dependent T7 RNA polymerase. Cell (1990) 1.19
The heptad repeat in the largest subunit of RNA polymerase II binds by intercalating into DNA. Nature (1990) 1.17
Regulation of polyadenylation of hepatitis delta virus antigenomic RNA. J Virol (1991) 1.16
Estimating kinetic parameters from dynamic contrast-enhanced T(1)-weighted MRI of a diffusable tracer: standardized quantities and symbols. J Magn Reson Imaging (1999) 13.26
Behavioral disinhibition and the development of substance-use disorders: findings from the Minnesota Twin Family Study. Dev Psychopathol (1999) 5.90
Initiation of replication of the human hepatitis delta virus genome from cloned DNA: role of delta antigen. J Virol (1989) 5.48
Diagnosis and management of aortic dissection. Eur Heart J (2001) 5.39
Structure and replication of the genome of the hepatitis delta virus. Proc Natl Acad Sci U S A (1986) 5.23
An investigation of traveller's diarrhoea. Lancet (1970) 4.99
Molecular cloning of hepatitis delta virus RNA from an infected woodchuck liver: sequence, structure, and applications. J Virol (1988) 4.96
Antigenomic RNA of human hepatitis delta virus can undergo self-cleavage. J Virol (1988) 4.59
A specific base transition occurs on replicating hepatitis delta virus RNA. J Virol (1990) 4.05
Characterization of self-cleaving RNA sequences on the genome and antigenome of human hepatitis delta virus. J Virol (1988) 4.05
The Emerging Risk Factors Collaboration: analysis of individual data on lipid, inflammatory and other markers in over 1.1 million participants in 104 prospective studies of cardiovascular diseases. Eur J Epidemiol (2007) 3.81
A randomized trial of acyclovir for 7 days or 21 days with and without prednisolone for treatment of acute herpes zoster. N Engl J Med (1994) 3.72
Role of two forms of hepatitis delta virus antigen: evidence for a mechanism of self-limiting genome replication. J Virol (1990) 3.57
Inhibition of interferon action by actinomycin. Biochem Biophys Res Commun (1964) 3.55
NYVAC: a highly attenuated strain of vaccinia virus. Virology (1992) 3.38
A study of Escherichia coli isolated from chronic urinary infection. J Med Microbiol (1969) 3.32
Template switching by reverse transcriptase during DNA synthesis. J Virol (1990) 2.98
Using nurses for preventive activities with computer assisted follow up: a randomised controlled trial. BMJ (1989) 2.95
Comparison of cromoglycate (cromolyn) and theophylline in controlling symptoms of chronic asthma. A collaborative study. Lancet (1977) 2.90
Distinctive molecular profiles of high-grade and low-grade gliomas based on oligonucleotide microarray analysis. Cancer Res (2001) 2.90
Cardiac T2* magnetic resonance for prediction of cardiac complications in thalassemia major. Circulation (2009) 2.85
Immunization against Diphtheria with Alum-precipitated Toxoid-II. Br Med J (1942) 2.77
Psychotic illness following 'mabi bark tea' consumption. Br J Psychiatry (1992) 2.72
The 6-min walk distance: change over time and value as a predictor of survival in severe COPD. Eur Respir J (2004) 2.63
Comparison of influenza serological techniques by international collaborative study. Vaccine (1994) 2.55
Stromal estrogen receptors mediate mitogenic effects of estradiol on uterine epithelium. Proc Natl Acad Sci U S A (1997) 2.54
MutS mediates heteroduplex loop formation by a translocation mechanism. EMBO J (1997) 2.52
A homeodomain protein related to caudal regulates intestine-specific gene transcription. Mol Cell Biol (1994) 2.42
Transient Induction of Phenylalanine Ammonia-Lyase and 4-Coumarate: CoA Ligase mRNAs in Potato Leaves Infected with Virulent or Avirulent Races of Phytophthora infestans. Plant Physiol (1987) 2.36
Replication of human hepatitis delta virus in primary cultures of woodchuck hepatocytes. J Virol (1987) 2.36
Assembly of hepatitis delta virus particles. J Virol (1992) 2.36
Structural asymmetries in the human brain: a voxel-based statistical analysis of 142 MRI scans. Cereb Cortex (2001) 2.32
Immunisation with canarypox virus expressing rabies glycoprotein. Lancet (1992) 2.09
Rapid immune response to influenza vaccination. Lancet (1993) 2.09
Roles of estrogen receptor-alpha gene expression in reproduction-related behaviors in female mice. Endocrinology (1998) 2.05
Phylogenetic aspects of C-reactive protein and related proteins. Ann N Y Acad Sci (1982) 2.03
Hepatitis delta virus genome replication: a polyadenylated mRNA for delta antigen. J Virol (1990) 2.03
Hereditary haemorrhagic telangiectasia, an Australian cohort: clinical and investigative features. Intern Med J (2014) 1.98
Reverse transcriptase of human immunodeficiency virus type 1: functionality of subunits of the heterodimer in DNA synthesis. J Virol (1992) 1.94
Molecular analysis of recrudescent parasites in a Plasmodium falciparum drug efficacy trial in Gabon. Trans R Soc Trop Med Hyg (1998) 1.91
Extremely long-lasting antagonistic actions of nor-binaltorphimine (nor-BNI) in the mouse tail-flick test. J Pharmacol Exp Ther (1992) 1.88
The stability and properties of bimolecular lipid leaflets in aqueous solutions. J Theor Biol (1963) 1.80
Self-ligating RNA sequences on the antigenome of human hepatitis delta virus. J Virol (1989) 1.78
Ketamine sedation for children in the emergency department. Emerg Med (Fremantle) (2001) 1.78
Cloned hepatitis delta virus cDNA is infectious in the chimpanzee. J Virol (1989) 1.75
Perindopril for elderly people with chronic heart failure: the PEP-CHF study. The PEP investigators. Eur J Heart Fail (1999) 1.75
A randomized controlled trial comparing oxytocin administration before and after placental delivery in the prevention of postpartum hemorrhage. Am J Obstet Gynecol (2001) 1.73
Outbreak of infantile gastro-enteritis caused by Escherichia coli O114. Arch Dis Child (1970) 1.71
The antigen of hepatitis delta virus: examination of in vitro RNA-binding specificity. J Virol (1991) 1.70
Isolation and characterization of C-reactive protein and serum amyloid P component in the rat. Immunology (1982) 1.67
Efficacy of nucleoprotein and haemagglutinin antigens expressed in fowlpox virus as vaccine for influenza in chickens. Vaccine (1991) 1.66
Cognitively unimpaired HIV-positive subjects do not have increased 11C-PiB: a case-control study. Neurology (2010) 1.66
Liposomal prostaglandin E1 (TLC C-53) in acute respiratory distress syndrome: a controlled, randomized, double-blind, multicenter clinical trial. TLC C-53 ARDS Study Group. Crit Care Med (1999) 1.65
Factors associated with early failure of arteriovenous fistulae for haemodialysis access. Eur J Vasc Endovasc Surg (1996) 1.65
Risks of young age for selected neurocognitive deficits in medulloblastoma are associated with white matter loss. J Clin Oncol (2001) 1.64
Controlling deaths from volatile substance abuse in under 18s: the effects of legislation. BMJ (1992) 1.63
The variation of capacitance and conductance of bimolecular lipid membranes with area. J Theor Biol (1965) 1.62
Acute lobar atelectasis. A comparison of two chest physiotherapy regimens. Chest (1990) 1.59
Neurocognitive deficits in medulloblastoma survivors and white matter loss. Ann Neurol (1999) 1.59
Long-term outcome of episodes of major depression. Clinical and public health significance. JAMA (1984) 1.58
Avoided and avoidable risks of cancer. Carcinogenesis (1997) 1.58
Negative regulation of the serine/threonine kinase B-Raf by Akt. J Biol Chem (2000) 1.58
Modifications of testosterone-dependent behaviors by estrogen receptor-alpha gene disruption in male mice. Endocrinology (1998) 1.57
Polar group orientation and the electrical properties of lecithin bimolecular leaflets. J Theor Biol (1965) 1.57
Combined Active and Passive Immunization against Diphtheria: II. Control of Epidemics in the Field. Br Med J (1941) 1.57
Ribonucleoprotein complexes of hepatitis delta virus. J Virol (1993) 1.56
Specificities involved in the initiation of retroviral plus-strand DNA. J Virol (1990) 1.55
Outcomes after seizure recurrence in people with well-controlled epilepsy and the factors that influence it. The MRC Antiepileptic Drug Withdrawal Group. Epilepsia (1996) 1.54
Glutathione S-transferase mu locus: use of genotyping and phenotyping assays to assess association with lung cancer susceptibility. Carcinogenesis (1991) 1.53
The influence of lipid composition and of some adsorbed proteins on the capacitance of black hydrocarbon membranes. J Theor Biol (1965) 1.51
Spin waves and revised crystal structure of honeycomb iridate Na2IrO3. Phys Rev Lett (2012) 1.49
Costs and outcomes in rheumatoid arthritis and osteoarthritis. Arthritis Rheum (1984) 1.49
Editing on the genomic RNA of human hepatitis delta virus. J Virol (1992) 1.48
A cluster randomised controlled trial to determine the clinical effectiveness and cost-effectiveness of classroom-based cognitive-behavioural therapy (CBT) in reducing symptoms of depression in high-risk adolescents. Health Technol Assess (2013) 1.46
Canal adaptation and coronal leakage: lateral condensation compared to Thermafil. J Am Dent Assoc (1995) 1.45
Surfactant-associated protein A inhibits LPS-induced cytokine and nitric oxide production in vivo. Am J Physiol Lung Cell Mol Physiol (2000) 1.45
Reprinted article "Factors associated with early failure of arteriovenous fistulae for haemodialysis access". Eur J Vasc Endovasc Surg (2011) 1.44
Bier's block--the experience of Australian emergency departments. Med J Aust (1994) 1.44
Human estrogen receptor beta binds DNA in a manner similar to and dimerizes with estrogen receptor alpha. J Biol Chem (1997) 1.42
BCL-X expression in multiple myeloma: possible indicator of chemoresistance. Cancer Res (1998) 1.41
Personality testing in 226 patients with urinary incontinence. Br J Urol (1986) 1.41
Trace element concentrations in patients on home enteral feeding: two cases of severe copper deficiency. Ann Clin Biochem (2005) 1.41
Wilfred Trotter: Presidential Address given at the meeting of the Surgical Section of The Royal Society of Medicine on 3rd November, 1948. Ann R Coll Surg Engl (1949) 1.41
Circumstances of sexual and physical victimization of black psychiatric outpatients. J Natl Med Assoc (1989) 1.41
The genetic heterogeneity of lactic acidosis: occurrence of recognizable inborn errors of metabolism in pediatric population with lactic acidosis. Pediatr Res (1980) 1.41
Obstetric care in rural Missouri: the loss of rural general and family practitioners. Mo Med (1990) 1.38
Rising age limit for kidney donors? Lancet (1989) 1.38
Sequence of the gene for alkaline phosphatase from Escherichia coli JM83. Nucleic Acids Res (1986) 1.38
Salmonella dublin: the relation between a living calf vaccine strain and those isolated from human and other sources. Vet Rec (1970) 1.36
When retroviral reverse transcriptases reach the end of their RNA templates. J Virol (1992) 1.36
Patients' priorities for medical care. Med Care (1983) 1.35
Salmonellosis: the present position in man and animals. II. Public health aspects. Vet Rec (1967) 1.34
Physiology: does gut hormone PYY3-36 decrease food intake in rodents? Nature (2004) 1.34
Personality and substance use disorders: I. Effects of gender and alcoholism subtype. Alcohol Clin Exp Res (1997) 1.33
Endogenous auxin and ethylene in pellia (bryophyta). Plant Physiol (1983) 1.33
Impulse rates and sensitivity to stretch of soleus muscle spindle afferent fibers during locomotion in premammillary cats. J Neurophysiol (1985) 1.32
Best ethical practices for clinicians and laboratories in the provision of noninvasive prenatal testing. Prenat Diagn (2013) 1.32
The TYCHO system for computer analysis of two-dimensional gel electrophoresis patterns. Clin Chem (1981) 1.31
Immunization against Diphtheria with Alum-precipitated Toxoid-I. Br Med J (1942) 1.31